Parkinson’s disease in the older patient Date: November 4, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Practice guideline update summary- Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Date: July 18, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson’s disease Date: July 18, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Feeding Choices for People with Advanced Parkinson’s Disease Date: March 11, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease Date: March 11, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Parkinson’s Disease: From Pathogenesis to Pharmacogenomics Date: March 11, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Parkinson’s disease: clinical features and diagnosis Date: March 11, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Mindfulness-based stress reduction in Parkinson’s disease: a systematic review Date: March 11, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Canadian Guidelines on Parkinson’s Disease Date: March 11, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
Double-Blind, Double-Dummy, Randomized Study of Continuous Intrajejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Date: March 11, 2019 By: echo_wpbaycrest_admin Categories: Movement Disorders Read More
